U.S. FDA Foreign Inspections User Fee Program Getting Push From Congress
This article was originally published in PharmAsia News
The pharmaceutical industry is facing an increasingly aggressive push to create user fees for manufacturing inspections
You may also be interested in...
FDA has its own programs, but a State Department undersecretary said enhancing training at FDA could boost efforts to fight drug counterfeiting and diversion.
Legislative fixes are required for U.S. FDA to implement its long-term strategy to use a coalition of regulators to secure the world drug supply chain, but the agency says it will not let that stop it from implementing its Pathway to Global Product Safety and Quality plan